脯氨酸羟化酶(PHDs)对动物骨骼肌发育和脂肪沉积的调控作用及其机制

doi:10.11843/j.issn.0366-6964.2024.03.001

摘要/Abstract

摘要： 在畜禽生产中，骨骼肌发育及脂肪沉积对产品品质具有重要影响，调控骨骼肌发育和脂肪沉积以提高畜禽胴体品质和肉品质对于养殖的提质增效具有重要意义。脯氨酸羟化酶（proline hydroxylases，PHD）是一类非血红素铁依赖性双加氧酶，它不仅是缺氧诱导因子信号通路的重要调控因子，还可以通过调节细胞内氧适应水平、细胞凋亡、细胞代谢和细胞转运等方面，参与机体多种生理功能。本文在介绍PHD的生理功能及其活性调节的基础上，总结了PHDs在动物骨骼肌发育及脂肪沉积中的调控作用，分析了其发挥作用的可能机制，以期为通过调控动物骨骼肌发育和脂肪沉积来提高畜禽产品品质提供新的思路和靶点。

关键词: 脯氨酸羟化酶, 骨骼肌发育, 脂肪沉积, 调控作用

Abstract: In livestock and poultry production,skeletal muscle development and fat deposition have an important effect on product quality. Regulating skeletal muscle development and fat deposition to improve carcass quality and meat quality of livestock and poultry is of great significance for improving the quality and efficiency of breeding industry. Proline hydroxylases(PHDs) are a class of non-heme iron-dependent dioxygenases that not only act as an important regulator of hypoxic-inducing factor signaling pathway,but also participate in many physiological functions by regulating oxygen adaptation level in cells,apoptosis,cell metabolism and cell transport. On the basis of introducing the physiological function and activity regulation of PHD,this paper summarized the regulatory role of PHDs in animal skeletal muscle development and fat deposition,and analyzed the possible mechanism of its role,in order to provide new ideas and targets for improving the quality of livestock and poultry products by regulating animal skeletal muscle development and fat deposition.

Key words: proline hydroxylases, skeletal muscle development, fat deposition, regulatory roles

中图分类号:

S852.2

梁淑怡, 李凡, 江青艳, 王松波. 脯氨酸羟化酶(PHDs)对动物骨骼肌发育和脂肪沉积的调控作用及其机制[J]. 畜牧兽医学报, 2024, 55(3): 867-873.

LIANG Shuyi, LI Fan, JIANG Qingyan, WANG Songbo. Regulation and Mechanism of Proline Hydroxylases(PHDs) on Skeletal Muscle Development and Fat Deposition in Animals[J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(3): 867-873.

参考文献

[1] MOHAMMADABADI M, BORDBAR F, JENSEN J, et al.Key genes regulating skeletal muscle development and growth in farm animals[J].Animals (Basel), 2021, 11(3):835.
[2] GHABEN A L, SCHERER P E.Adipogenesis and metabolic health[J].Nat Rev Mol Cell Biol, 2019, 20(4):242-258.
[3] 夏冰清, 杨帆, 张硕.脯氨酰羟化酶研究进展及其与肿瘤的关系[J].南通大学学报(医学版), 2010, 30(2):142-145, 147.
XIA B Q, YANG F, ZHANG S.Research progress of prolyl hydroxylase and the relationship with tumor[J].Journal of Nantong University (Medical Sciences), 2010, 30(2):142-145, 147.(in Chinese)
[4] 刘思雨, 任彩霞.脯氨酸羟化酶在乳腺癌中的研究进展[J].中华肿瘤防治杂志, 2023, 30(14):876-880, 886.
LIU S Y, REN C X.Research progress of prolyl hydroxylase domain in breast cancer[J].Chinese Journal of Cancer Prevention and Treatment, 2023, 30(14):876-880, 886.(in Chinese)
[5] APPELHOFF R J, TIAN Y M, RAVAL R R, et al.Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor[J].J Biol Chem, 2004, 279(37):38458-38465.
[6] IVAN M, HABERBERGER T, GERVASI D C, et al.Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor[J].Proc Natl Acad Sci U S A, 2002, 99(21):13459-13464.
[7] ELTZSCHIG H K, BRATTON D L, COLGAN S P.Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases[J].Nat Rev Drug Discov, 2014, 13(11):852-869.
[8] RABINOWITZ M H.Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors:tricking the body into mounting orchestrated survival and repair responses[J].J Med Chem, 2013, 56(23):9369-9402.
[9] ZHAO Y C, XIONG W D, LI C F, et al.Hypoxia-induced signaling in the cardiovascular system:pathogenesis and therapeutic targets[J].Signal Transduct Target Ther, 2023, 8(1):431.
[10] KUROKAWA H, ITO H, TERASAKI M, et al.Nitric oxide regulates the expression of heme carrier protein-1 via hypoxia inducible factor-1α stabilization[J].PLoS One, 2019, 14(9):e0222074.
[11] FISCHER A P, MILES S L.Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor-1 alpha activity and reduce malignant potential in human melanoma[J].Biomed Pharmacother, 2017, 86:502-513.
[12] LI L, SHEN S S, BICKLER P, et al.Searching for molecular hypoxia sensors among oxygen-dependent enzymes[J].eLife, 2023, 12:e87705.
[13] OGAWA C, TSUCHIYA K, MAEDA K.Hypoxia-inducible factor prolyl hydroxylase inhibitors and iron metabolism[J].Int J Mol Sci, 2023, 24(3):3037.
[14] ASCHNER M, SKALNY A V, LU R Z, et al.The role of hypoxia-inducible factor 1 alpha (HIF-1α) modulation in heavy metal toxicity[J].Arch Toxicol, 2023, 97(5):1299-1318.
[15] FRUMP A L, SELEJ M, WOOD J A, et al.Hypoxia upregulates estrogen receptor β in pulmonary artery endothelial cells in a HIF-1α-dependent manner[J].Am J Respir Cell Mol Biol, 2018, 59(1):114-126.
[16] NGUYEN T L, DURÁN R V.Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism[J].Int J Biochem Cell Biol, 2016, 80:71-80.
[17] INFANTINO V, SANTARSIERO A, CONVERTINI P, et al.Cancer cell metabolism in hypoxia:role of HIF-1 as key regulator and therapeutic target[J].Int J Mol Sci, 2021, 22(11):5703.
[18] GLORIEUX C, CALDERON P B.Vitamin C (ascorbate) and redox topics in cancer[J].Antioxid Redox Signal, 2021, 35(14):1157-1175.
[19] BARROS D, MARQUES E A, MAGALHÃES J, et al.Energy metabolism and frailty:the potential role of exercise-induced myokines-A narrative review[J].Ageing Res Rev, 2022, 82:101780.
[20] SMITH J A B, MURACH K A, DYAR K A, et al.Exercise metabolism and adaptation in skeletal muscle[J].Nat Rev Mol Cell Biol, 2023, 24(9):607-632.
[21] YAN X, ZHU M J, DODSON M V, et al.Developmental programming of fetal skeletal muscle and adipose tissue development[J]. J Genomics, 2013, 1:29-38.
[22] RIM E Y, CLEVERS H, NUSSE R.The wnt pathway:from signaling mechanisms to synthetic modulators[J].Annu Rev Biochem, 2022, 91:571-598.
[23] SHEN X M, TANG J, JIANG R, et al.CircRILPL1 promotes muscle proliferation and differentiation via binding miR-145 to activate IGF1R/PI3K/AKT pathway[J].Cell Death Dis, 2021, 12(2):142.
[24] SAKUSHIMA K, YOSHIKAWA M, OSAKI T, et al.Moderate hypoxia promotes skeletal muscle cell growth and hypertrophy in C2C12 cells[J].Biochem Biophys Res Commun, 2020, 525(4):921-927.
[25] FU J, MENZIES K, FREEMAN R S, et al.EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability[J].J Biol Chem, 2007, 282(17):12410-12418.
[26] 付玉, 张博, 凌遥, 等.骨骼肌生长发育过程及调控研究现状[J].中国畜牧兽医, 2021, 48(10):3565-3574.
FU Y, ZHANG B, LING Y, et al.Reviews on process and regulation of skeletal muscle growth and development[J].China Animal Husbandry & Veterinary Medicine, 2021, 48(10):3565-3574.(in Chinese)
[27] D'HULST G, SORO-ARNAIZ I, MASSCHELEIN E, et al.PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase[J].Nat Commun, 2020, 11(1):174.
[28] DESCHOEMAEKER S, DI CONZA G, LILLA S, et al.PHD1 regulates p53-mediated colorectal cancer chemoresistance[J]. EMBO Mol Med, 2015, 7(10):1350-1365.
[29] WOLFSON R L, SABATINI D M.The Dawn of the age of amino acid sensors for the mTORC1 pathway[J].Cell Metab, 2017, 26(2):301-309.
[30] SHIN J, NUNOMIYA A, KITAJIMA Y, et al.Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway[J].Skelet Muscle, 2016, 6:5.
[31] NUNOMIYA A, SHIN J, KITAJIMA Y, et al.Activation of the hypoxia-inducible factor pathway induced by prolyl hydroxylase domain 2 deficiency enhances the effect of running training in mice[J].Acta Physiol (Oxf), 2017, 220(1):99-112.
[32] YOON H, SPINELLI J B, ZAGANJOR E, et al.PHD3 loss promotes exercise capacity and fat oxidation in skeletal muscle[J].Cell Metab, 2020, 32(2):215-228.e7.
[33] LADEROUTE K R, AMIN K, CALAOAGAN J M, et al.5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments[J].Mol Cell Biol, 2006, 26(14):5336-5347.
[34] GERMAN N J, YOON H, YUSUF R Z, et al.PHD3 loss in cancer enables metabolic reliance on fatty acid oxidation via deactivation of ACC2[J].Mol Cell, 2016, 63(6):1006-1020.
[35] CAI X C, YUAN Y X, LIAO Z R, et al.α-Ketoglutarate prevents skeletal muscle protein degradation and muscle atrophy through PHD3/ADRB2 pathway[J].FASEB J, 2018, 32(1):488-499.
[36] LI F, YIN C, MA Z W, et al.PHD3 mediates denervation skeletal muscle atrophy through Nf-κB signal pathway[J].FASEB J, 2021, 35(4):e21444.
[37] MERRICK M A.Secondary injury after musculoskeletal trauma:a review and update[J].J Athl Train, 2002, 37(2):209-217.
[38] ZHANG J, KASIM V, XIE Y D, et al.Inhibition of PHD3 by salidroside promotes neovascularization through cell-cell communications mediated by muscle-secreted angiogenic factors[J].Sci Rep, 2017, 7:43935.
[39] RISHI M T, SELVARAJU V, THIRUNAVUKKARASU M, et al.Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia[J].Microvasc Res, 2015, 97:181-188.
[40] SETTELMEIER S, SCHREIBER T, MÄKI J, et al.Prolyl hydroxylase domain 2 reduction enhances skeletal muscle tissue regeneration after soft tissue trauma in mice[J].PLoS One, 2020, 15(5):e0233261.
[41] SINHA I, SAKTHIVEL D, OLENCHOCK B A, et al.Prolyl hydroxylase domain-2 inhibition improves skeletal muscle regeneration in a male murine model of obesity[J].Front Endocrinol (Lausanne), 2017, 8:153.
[42] GHABEN A L, SCHERER P E.Adipogenesis and metabolic health[J].Nat Rev Mol Cell Biol, 2019, 20(4):242-258.
[43] CHO Y K, LEE S, LEE J, et al.Lipid remodeling of adipose tissue in metabolic health and disease[J].Exp Mol Med, 2023, 55(9):1955-1973.
[44] FLOYD Z E, KILROY G, WU X Y, et al.Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions[J].J Cell Biochem, 2007, 101(6):1545-1557.
[45] KIM J, KWAK H J, CHA J Y, et al.The role of prolyl hydroxylase domain protein (PHD) during rosiglitazone-induced adipocyte differentiation[J].J Biol Chem, 2014, 289(5):2755-2764.
[46] RAHTU-KORPELA L, KARSIKAS S, HÖRKKÖ S, et al.HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction[J].Diabetes, 2014, 63(10):3324-3333.
[47] SUGAHARA M, TANAKA S, TANAKA T, et al.Prolyl hydroxylase domain inhibitor protects against metabolic disorders and associated kidney disease in obese type 2 diabetic mice[J].J Am Soc Nephrol, 2020, 31(3):560-577.
[48] ZHANG L, LI M M, CORCORAN M, et al.Essential roles of insulin, AMPK signaling and lysyl and prolyl hydroxylases in the biosynthesis and multimerization of adiponectin[J].Mol Cell Endocrinol, 2015, 399:164-177.
[49] LEFERE S, VAN STEENKISTE C, VERHELST X, et al.Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease[J].Cell Mol Life Sci, 2016, 73(18):3419-3431.
[50] THOMAS A, BELAIDI E, ARON-WISNEWSKY J, et al.Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice[J].Sci Rep, 2016, 6:24618.
[51] NASTESKA D, CUOZZO F, VILORIA K, et al.Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in mice[J].JCI Insight, 2021, 6(16):e140288.
[52] TANIGUCHI C M, FINGER E C, KRIEG A J, et al.Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes[J].Nat Med, 2013, 19(10):1325-1330.
[53] BERTHOLET A M, KIRICHOK Y.UCP1:a transporter for H⁺ and fatty acid anions[J].Biochimie, 2017, 134:28-34.
[54] GOMEZ SALAZAR M, PRUÑONOSA CERVERA I, WANG R L, et al.Adipocyte-specific deletion of the oxygen-sensor PHD2 sustains elevated energy expenditure at thermoneutrality[J].bioRxiv, 2021, 1(5):425401.
[55] LI F, ZHANG F L, YI X, et al.Proline hydroxylase 2 (PHD2) promotes brown adipose thermogenesis by enhancing the hydroxylation of UCP1[J].Mol Metab, 2023, 73:101747.